Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENCA macrobeads in metastatic colorectal carcinoma
NCT02046174Phase 2Completed
- Sponsor
- Rogosin Institute
- Start
- Apr 2014
- Primary completion
- Oct 2018
- Modality
- Cell Therapies, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RENCA macrobeads in colorectal carcinoma (CRC), sponsored by Rogosin Institute. Started Apr 2014; status: completed.
02
Drugs
RENCA macrobeads
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT02046174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046174.